LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - ResMed (NYSE: RMD)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NYSE RMD ResMed
Farrell Michael J. / officer: Chief Executive Officer
10/07/2025
Buy
$101.64
8,009
$814K
475,801
NYSE RMD ResMed
Farrell Michael J. / officer: Chief Executive Officer
10/07/2025
Sell
$282.85
8,009
$2.265M
467,792
NYSE RMD ResMed
Farrell Michael J. / officer: Chief Executive Officer
10/07/2025
Sell
$101.64
8,009
$814K
8,011
NYSE RMD ResMed
Sandercock Brett / officer: Chief Financial Officer
10/01/2025
Buy
$101.64
2,000
$203K
89,745
NYSE RMD ResMed
Sandercock Brett / officer: Chief Financial Officer
10/01/2025
Sell
$274.36
3,000
$823K
86,745
NYSE RMD ResMed
Sandercock Brett / officer: Chief Financial Officer
10/01/2025
Sell
$101.64
2,000
$203K
2,000
NYSE RMD ResMed
Rider Michael J / officer: Global General Counsel
10/01/2025
Sell
$274.36
100
$27K
11,327
NYSE RMD ResMed
Farrell Michael J. / officer: Chief Executive Officer
09/08/2025
Buy
$101.64
8,009
$814K
475,801
NYSE RMD ResMed
Farrell Michael J. / officer: Chief Executive Officer
09/08/2025
Sell
$278.14
8,009
$2.228M
467,792
NYSE RMD ResMed
Farrell Michael J. / officer: Chief Executive Officer
09/08/2025
Sell
$101.64
8,009
$814K
16,020